237 related articles for article (PubMed ID: 18757665)
21. Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia.
Agorastos T; Vaitsi V; Paschopoulos M; Vakiani A; Zournatzi-Koiou V; Saravelos H; Kostopoulou E; Constantinidis T; Dinas K; Vavilis D; Lolis D; Bontis J
Maturitas; 2004 Jun; 48(2):125-32. PubMed ID: 15172086
[TBL] [Abstract][Full Text] [Related]
22. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
23. The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
Kroiss R; Fentiman IS; Helmond FA; Rymer J; Foidart JM; Bundred N; Mol-Arts M; Kubista E
BJOG; 2005 Feb; 112(2):228-33. PubMed ID: 15663589
[TBL] [Abstract][Full Text] [Related]
24. Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen.
Klaassens AH; van Wijk FH; Hanifi-Moghaddam P; Sijmons B; Ewing PC; Ten Kate-Booij MJ; Kooi GS; Kloosterboer HJ; Blok LJ; Burger CW
Fertil Steril; 2006 Aug; 86(2):352-61. PubMed ID: 16828477
[TBL] [Abstract][Full Text] [Related]
25. Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low-dose estrogen or tibolone treatment: a comparison.
Botsis D; Kassanos D; Kalogirou D; Antoniou G; Vitoratos N; Karakitsos P
Maturitas; 1997 Jan; 26(1):57-62. PubMed ID: 9032748
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic findings in women with postmenopausal bleeding: implication for endometrial thickness and circulating levels of sex steroid hormones.
Yildirim M; Bozkurt N; Kurdoglu M; Taskiran C; Oktem M; Dilek KU
Arch Gynecol Obstet; 2007 Oct; 276(4):305-10. PubMed ID: 17410372
[TBL] [Abstract][Full Text] [Related]
27. [Endometrial growth in continuous, estrogen substitution monotherapy with Estraderm TTS (0.05 mg/die) in 31 postmenopausal females].
Meuwissen JH; van Langen H; Nielen M
Geburtshilfe Frauenheilkd; 1992 Jun; 52(6):351-4. PubMed ID: 1634098
[TBL] [Abstract][Full Text] [Related]
28. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
Kelly P; Dobbs SP; McCluggage WG
BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
[TBL] [Abstract][Full Text] [Related]
29. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study.
Unfer V; Casini ML; Costabile L; Mignosa M; Gerli S; Di Renzo GC
Fertil Steril; 2004 Jul; 82(1):145-8, quiz 265. PubMed ID: 15237003
[TBL] [Abstract][Full Text] [Related]
30. Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial.
Kubista E; Planellas Gomez JV; Dowsett M; Foidart JM; Pohlodek K; Serreyn R; Nechushkin M; Manikhas AG; Semiglazov VF; Hageluken CC; Singer CF
Clin Cancer Res; 2007 Jul; 13(14):4185-90. PubMed ID: 17634547
[TBL] [Abstract][Full Text] [Related]
31. Assessment of DNA damage in postmenopausal women under osteoporosis therapy.
Bayram M; Soyer C; Kadioglu E; Sardas S
Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):227-30. PubMed ID: 16504368
[TBL] [Abstract][Full Text] [Related]
32. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women.
Manonai J; Chittacharoen A; Udomsubpayakul U; Theppisai H; Theppisai U
Menopause; 2008; 15(3):530-5. PubMed ID: 18202589
[TBL] [Abstract][Full Text] [Related]
33. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
Kenemans P; Speroff L;
Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
[TBL] [Abstract][Full Text] [Related]
34. Complex endometrial hyperplasia in the context of tibolone administration.
Kane SC; Quinn MA
Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):338-9. PubMed ID: 19566575
[No Abstract] [Full Text] [Related]
35. Balancing safety and efficacy focus on endometrial protection.
Boroditsky RS
J Reprod Med; 2000 Mar; 45(3 Suppl):273-84. PubMed ID: 10756508
[TBL] [Abstract][Full Text] [Related]
36. Effects of subdermal implants of estradiol and testosterone on the endometrium of postmenopausal women.
Filho AM; Barbosa IC; Maia H; Genes CC; Coutinho EM
Gynecol Endocrinol; 2007 Sep; 23(9):511-7. PubMed ID: 17943546
[TBL] [Abstract][Full Text] [Related]
37. The effects of tibolone in older postmenopausal women.
Cummings SR; Ettinger B; Delmas PD; Kenemans P; Stathopoulos V; Verweij P; Mol-Arts M; Kloosterboer L; Mosca L; Christiansen C; Bilezikian J; Kerzberg EM; Johnson S; Zanchetta J; Grobbee DE; Seifert W; Eastell R;
N Engl J Med; 2008 Aug; 359(7):697-708. PubMed ID: 18703472
[TBL] [Abstract][Full Text] [Related]
38. [The influence of a tibolone therapy on endometrium in postmenopausal women].
Szlendak-Sauer K; Wierzba W; Radowicki S
Ginekol Pol; 2008 Nov; 79(11):758-61. PubMed ID: 19140498
[TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy (HRT) and endometrial morphology under consideration of the different molecular pathways in endometrial carcinogenesis.
Horn LC; Dietel M; Einenkel J
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):4-12. PubMed ID: 15927347
[TBL] [Abstract][Full Text] [Related]
40. Hormone replacement therapy and the endometrium.
Daayana S; Holland CM
Menopause Int; 2009 Sep; 15(3):134-8. PubMed ID: 19723685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
